Phase 1 Prostatic Hyperplasia Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects
Benign Prostatic Hyperplasia
Addpharma Inc.44 enrolled1 locationNCT07444385
Recruiting
Phase 1
Effetivity of Dutasteride and Aloe Vera Extract Combination on Angiogenesis and Obstruction on Benign Prostatic Hyperplasia
BPH (Benign Prostatic Hyperplasia)
Universitas Diponegoro84 enrolled1 locationNCT07065682
Completed
Phase 1
Comparative assessment of the absorption of a generic formulation of tamsulosin tablet against the innovator tamsulosin tablet conducted under fasting condition and at steady state in healthy male and female volunteers.
Tamsulosin is indicated for the relief of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
Zenith Technology Corporation Limited24 enrolled1 locationACTRN12618001147279
Completed
Phase 1
Comparative assessment of the absorption of a generic formulation of tamsulosin tablet against the innovator tamsulosin tablet conducted under fed condition in healthy male and female volunteers.
Tamsulosin is indicated for the relief of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
Zenith Technology Corp Ltd28 enrolled1 locationACTRN12618001051235
Completed
Phase 1
Comparative assessment of the absorption of a generic formulation of tamsulosin tablet against the innovator tamsulosin tablet conducted under fasting condition in healthy male and female volunteers.
Tamsulosin is indicated for the relief of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).
Zenith Technology Corporation Limited28 enrolled1 locationACTRN12618000776202